Evaluation of the role of P-glycoprotein in the uptake of paroxetine, clozapine, phenytoin and carbamazapine by bovine retinal endothelial cells

Neuropharmacology

Volumn 49, Issue 5, 2005, Pages 610-617

  Maines, Lynn W ^a   Antonetti, David A ^a   Wolpert, Ellen B ^a   Smith, Charles D ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Blood brain barrier; Carbamazapine; Clozapine; P glycoprotein; Paroxetine; Phenytoin

Indexed keywords

CARBAMAZEPINE; CLOZAPINE; GLYCOPROTEIN P; HYDROCORTISONE; PAROXETINE; PGP 4008; PHENYTOIN; VERAPAMIL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG TRANSPORT; DRUG UPTAKE; ENDOTHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA CELL; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; BLOTTING, WESTERN; CARBAMAZEPINE; CATTLE; CELL SEPARATION; CELLS, CULTURED; CEREBRAL CORTEX; CLOZAPINE; ENDOTHELIAL CELLS; HYDROCORTISONE; P-GLYCOPROTEIN; PAROXETINE; PHENYTOIN; RATS; RETINA; SEROTONIN UPTAKE INHIBITORS;

EID: 23944455088     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2005.04.028     Document Type: Article

References (41)

1. N.J. Abbott, and I.A. Romero Transporting therapeutics across the blood-brain barrier Mol. Med. Today 2 3 1996 106 113
2. D.A. Antonetti Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin J. Neurochem. 80 4 2002 667 677
3. D.A. Antonetti, and E.B. Wolpert Isolation and characterization of retinal endothelial cells Methods Mol. Med. 89 2004 365 374
4. A. Ayrton, and P. Morgan Role of transport proteins in drug absorption, distribution and excretion Xenobiotica 31 8-9 2001 469 497
5. R.R. Bies, K.L. Bigos, and B.G. Pollock Gender differences in the pharmacokinetics and pharmacodynamics of antidepressants J. Gender Specific Med. 6 3 2003 12 20
6. P. Bohlen, S. Stein, W. Dairman, and S. Udenfriend Fluormetric assay of proteins in the nanogram range Arch. Biochem. Biophys. 155 1973 213 220
7. D.W. Boulton, C.L. DeVane, H.L. Liston, and J.S. Markowitz In vitro P-glycoprotein affinity for atypical and conventional antipsychotics Life Sci. 71 2 2002 163 169
8. J.R. Burdo Mechanisms and regulation of transferrin and iron transport in a model blood-brain barrier system Neuroscience 121 4 2003 883 890
9. L.M. Chan, S. Lowes, and B.H. Hirst The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability Eur. J. Pharm. Sci. 21 1 2004 25 51
10. S. Choudhuri Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats Drug Metab. Dispos. 31 11 2003 1337 1345
11. S. Cisternino Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier Cancer Res. 64 9 2004 3296 3301
12. C. Cordon-Cardo Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites Proc. Natl. Acad. Sci. USA 86 2 1989 695 698
13. V. De Luca Investigation of polymorphism in the MDR1 gene and antidepressant-induced mania Pharmacogenomics J. 3 5 2003 297 299
14. A.A. El Ela Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds-implications for pharmacokinetics of selected substrates J. Pharm. Pharmacol. 56 8 2004 967 975
15. M.F. Fromm Importance of P-glycoprotein for drug disposition in humans Eur. J. Clin. Invest. 33 Suppl. 2 2003 6 9
16. J.F. Ghersi-Egea, and N. Strazielle Choroid plexus transporters for drugs and other xenobiotics J. Drug Target 10 4 2002 353 357
17. J. Greenwood Characterization of a rat retinal endothelial cell culture and the expression of P-glycoprotein in brain and retinal endothelium in vitro J. Neuroimmunol. 39 1-2 1992 123 132
18. F.R. Haselton Modulation of retinal endothelial barrier in an in vitro model of the retinal microvasculature Exp. Eye Res. 63 2 1996 211 222
19. E.M. Kaplan Efficacy of venlafaxine in patients with major depressive disorder who have unsustained or no response to selective serotonin reuptake inhibitors: an open-label, uncontrolled study Clin. Ther. 24 7 2002 1194 1200
20. J.R. Kunta, and P.J. Sinko Intestinal drug transporters: in vivo function and clinical importance Curr. Drug Metab. 5 1 2004 109 124
21. E.C. de Lange Potential role of ABC transporters as a detoxification system at the blood-CSF barrier Adv. Drug Deliv. Rev. 56 12 2004 1793 1809
22. G. Lee, and R. Bendayan Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders Pharm. Res. 21 8 2004 1313 1330
23. B.D. Lee, Z. Li, K.J. French, Y. Zhuang, Z. Xia, and C.D. Smith Synthesis and evaluation of dihydropyrroloquinolines that selectively antagonize P-glycoprotein J. Med. Chem. 47 6 2004 1413 1422
24. T. Litman Competitive, non-competitive and cooperative interactions between substrates of P-glycoprotein as measured by its ATPase activity Biochim. Biophys. Acta 1361 2 1997 169 176
25. W. Loscher, and H. Potschka Role of multidrug transporters in pharmacoresistance to antiepileptic drugs J. Pharmacol. Exp. Ther. 301 1 2002 7 14
26. N. Maki, P. Hafkemeyer, and S. Dey Allosteric modulation of human P-glycoprotein. Inhibition of transport by preventing substrate translocation and dissociation J. Biol. Chem. 278 20 2003 18132 18139
27. C. Pantelis, and T.J. Lambert Managing patients with "treatment- resistant" schizophrenia Med. J. Aust. 178 2003 S62 S66
28. H. Potschka, and W. Loscher In vivo evidence for P-glycoprotein-mediated transport of phenytoin at the blood-brain barrier of rats Epilepsia 42 10 2001 1231 1240
29. H. Potschka, M. Fedrowitz, and W. Loscher Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity J. Pharmacol. Exp. Ther. 306 1 2003 124 131
30. M. Rizzi Limbic seizures induce P-glycoprotein in rodent brain: functional implications for pharmacoresistance J. Neurosci. 22 14 2002 5833 5839
31. N. Romiti, G. Tramonti, and E. Chieli Influence of different chemicals on MDR-1 P-glycoprotein expression and activity in the HK-2 proximal tubular cell line Toxicol. Appl. Pharmacol. 183 2 2002 83 91
32. A.H. Schinkel P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs J. Clin. Invest. 97 11 1996 2517 2524
33. E. Seree Modulation of MDR1 and CYP3A expression by dexamethasone: evidence for an inverse regulation in adrenals Biochem. Biophys. Res. Commun. 252 2 1998 392 395
34. J. Shen Evaluation of an immortalized retinal endothelial cell line as an in vitro model for drug transport studies across the blood-retinal barrier Pharm. Res. 20 9 2003 1357 1363
35. S.M. Sisodiya Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy Brain 125 Pt 1 2002 22 31
36. T. Terasaki, and K. Hosoya The blood-brain barrier efflux transporters as a detoxifying system for the brain Adv. Drug Deliv. Rev. 36 2-3 1999 195 209
37. R.Z. Turncliff, P.J. Meier, and K.L. Brouwer Effect of dexamethasone treatment on the expression and function of transport proteins in sandwich-cultured rat hepatocytes Drug Metab. Dispos. 32 8 2004 834 839
38. M. Uhr, M.T. Grauer, and F. Holsboer Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption Biol. Psychiatry 54 8 2003 840 846
39. J. Weiss Interaction of antiepileptic drugs with human P-glycoprotein in vitro J. Pharmacol. Exp. Ther. 307 1 2003 262 267
40. J. Weiss Inhibition of P-glycoprotein by newer antidepressants J. Pharmacol. Exp. Ther. 305 1 2003 197 204
41. M.A. Zamorski, and R.C. Albucher What to do when SSRIs fail: eight strategies for optimizing treatment of panic disorder Am. Fam. Physician 66 8 2002 1477 1484